Melissa Bailey is a Boston-based reporter on the KHN enterprise team, focusing on end-of-life issues. She joined KHN from STAT, where she was the national health care reporter.
The guide is being rolled out at Mass. General, Baylor Scott & White Health in Texas, Lowell General Hospital in Massachusetts, the University of Pennsylvania and hospitals in 34 foreign countries, said Dr. Rachelle Bernacki of the Serious Illness Care Program at Ariadne Labs.
There are 77 drugs to treat Alzheimer's disease currently being investigated or developed, according to the trade group PhRMA. Many observers still hold out hope for Biogen anti-amyloid drug — aducanumab.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.